UNSPSC 51192008: Febuxostat
Commodity
Code facts
- Part of
-
-
51000000
-
51190000
- 51192000
-
51190000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51192008
| NIGP code |
|---|
| 26987 Therapeutic Agents, Unclassified |
Definition
This classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula C16H16N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 101V0R1N2E, chemically known as 5-thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl- but generally known as febuxostat, which bears US NIH Compound Identifier 134018. European Medicines Agency schedules Febuxostat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25382.
Read the full definition
The term FEBUXOSTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). World Health Organization schedules febuxostat in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule febuxostat under HS 29341000 and SITC 51579. As of Q4 2014, FEBUXOSTAT remains the US FDA Preferred Term for this commodity. Febuxostat bears US NLM identifiers UMLS ID C2683462 and NCI Concept Code C65629. SMILES: S1C(NC(C1C(=O)O)C)C1CC(C(OCC(C)C)CC1)C#N.
About UNSPSC 51192008
UNSPSC 51192008 Febuxostat is a Commodity code for a specific xanthine oxidase inhibitor pharmaceutical used to treat gout and hyperuricemia. The recent state and local procurement activity tagged under this code does not match its pharmaceutical scope—the opportunities posted involve athletic training services, medical aid supplies, and pharmacy benefit program information gathering, none of which involve febuxostat or urate-lowering therapy procurement. State and local governments do source febuxostat through Medicaid and public employee health plans, but the three recent opportunities in the source represent misalignment between the code assignment and the actual goods or services being solicited.
The geographic spread of recent activity includes Texas, Arizona, and Florida, though the activities are orthogonal to the code's pharmaceutical focus. The City of Tucson posted an RFP (Solicitation 260163, response due June 9, 2026) for athletic training services for fire and police personnel; the City of Tampa issued an ITB (25-P-00157) for medical aid supplies with a $100,000 departmental budget and set-asides for Small Local Business Enterprises and U-WMBEs; and the Texas Health and Human Services Commission issued an RFI (HHS0017013, response deadline April 3, 2026) to explore direct-to-manufacturer prescription fulfillment capabilities. This code shows no active, relevant recent procurement opportunities for febuxostat itself and warrants reassessment of its tagging in the state and local opportunity dataset.
Quick answers
What is UNSPSC 51192008?
UNSPSC 51192008 is Febuxostat, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51192008?
UNSPSC 51192008 maps to 1 NIGP code, 26987 Therapeutic Agents, Unclassified.
On GovTribe
See everything under UNSPSC 51192008
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code